Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) (Q63338647)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) |
clinical trial |
Statements
CANTOS (English)
0 references
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-myocardial Infarction Patients With Elevated hsCRP (English)
0 references
11 April 2011
0 references
28 March 2017
0 references
10,071
0 references
18 year
0 references